Curvebeam Ai Ltd. · ASX:CVB
Curvebeam Ai — Shareholder Meeting (November 2024)
11 slides from Curvebeam Ai's shareholder meeting presentation, Nov 26, 2024
Slide 1: CEO Presentation - AGM 26th November 2024
For personal use only CEO PRESENTATION AGM - 26th November 2024
Slide 2: Disclaimer
DISCLAIMER Introduction THIS DOCUMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, Forward looking statements For personal use only DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA OR TO ANY The information given in this presentation is given for illus
Slide 3: CurveBeam AI Medical Device Business
AGM PRESENTATION CURVEBEAM AI MEDICAL DEVICE BUSINESS NOVEMBER 2024 For personal use only • First to market, bilateral weight bearing CT scans First to market • Enhanced HiRiseTM CT provides in-office high-resolution 3D scans & future AI aided clinical assessment (subject to regulatory clearance) •
Slide 4: Weight Bearing CT Overview
WEIGHT BEARING CT OVERVIEW ü Quicker and easier to scan than traditional CT and MRI, ü Radiation dose lower than traditional CT – for V1 HiRise up to For personal use only with faster image acquisition time 66% less than traditional CT ü High resolution and 3D visualisation enables ü Smaller and low
Slide 5: Stryker Foot & Ankle Co-Marketing & Distribution US Partnership
STRYKER FOOT & ANKLE CO-MARKETING & DISTRIBUTION US PARTNERSHIP For personal use only US F&A division has access to 500 reps and 40 regional Sales Managers STRYKER CORPORATION (NYSE:SYK) BACKGROUND • CurveBeam AI agreement is with the Foot & Ankle (F&A) division (2022) • May 23, F&A launched the HiR
Slide 6: Two Business Models
TWO BUSINESS MODELS Existing reimbursement codes/coverage targeted to drive both business models For personal use only 1. Present HiRise CT Business Model • Stryker sells HiRise for US$410,000 (circa A$630,000) Daily patient volume through a USA group surgeon office • CurveBeam AI transfers HiRise t
Slide 7: FY24 Key Metrics by Quarter
In Market FY24 KEY METRICS BY QUARTER Device Purchase Orders Q1 Q2 Q3 Q4 US 2 2 3 5 For personal use only Rest of World 1 2 3 5 Total 3 4 6 10 Device Purchase Orders by Region 12 10 8 TM 6 4 2 0 Q1 Q2 Q3 Q4 Discontinued US Rest of World 10 7 6 4 4 3 3 3 3 3 0 0 FY24 Q1 FY24 Q2 FY24 Q3 FY 24 Q4 Total
Slide 8: FY24 Key Metrics & Activities
FY24 KEY METRICS & ACTIVITIES For personal use only • CurveBeam AI received purchase orders (POs) for 23 devices in FY24. • The Company submitted its 510(k) application for the enhanced HiRise™ in Q4 FY24 and clearance was received in July 2024. • Enhanced HiRise™ designed to offer patient specific
Slide 9: FY24 Revenue and Net Loss
FY24 REVENUE AND NET LOSS For personal use only • Full year revenue for FY24 was A$6.5m, down from A$8.1m in FY23, or A$11.5m pro-forma for FY23. • The POs received in 4Q FY24 represent A$4.9m which will be recognised in FY25 as devices are shipped and installed. • FY25 began with ~75% of FY24’s exp
Slide 10: In Closing
IN CLOSING For personal use only • Enhanced HiRise™ validation progressing – scanning recommenced in November 24. • Company expects to have submitted all requested datasets and supporting documentation to the vendor for review and validation by early December. • CVB expects to be able to update the
Slide 11: Definitions
DEFINITIONS For personal use only CurveBeam AI’s key metrics are defined and interpreted as follows: • Purchase order – a signed purchase order (PO) for a CT scanner (device). The Company considers POs to be a key metric as it reflects actual sales at any given time. • Receipts from customers – any